ZNF792 inhibitors are a class of chemical compounds designed to target and modulate the activity of ZNF792, a zinc finger protein that belongs to a broader family of zinc finger transcription factors. Zinc finger proteins are characterized by their structural motifs, which coordinate zinc ions to stabilize their folds, enabling them to bind to DNA, RNA, or other proteins. These proteins play essential roles in regulating gene expression, chromatin remodeling, and cellular differentiation by recognizing specific DNA sequences and mediating transcriptional responses. ZNF792, in particular, is known for its involvement in various biological processes through interactions with other cellular proteins and genomic elements. Inhibitors of ZNF792 are developed to disrupt its interactions, typically by interfering with the zinc finger domains, thereby altering the binding affinity or specificity for target DNA sequences or other molecular partners.
The design of ZNF792 inhibitors often relies on understanding the structural features of zinc finger motifs and the molecular interactions that govern their function. Researchers utilize structural biology techniques, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, to map out the binding sites of ZNF792 and to identify key regions where chemical compounds can bind and modulate its activity. By targeting these critical sites, ZNF792 inhibitors can serve as valuable tools in molecular biology to study the regulatory functions of ZNF792 within cells, allowing for a deeper understanding of gene expression and chromatin dynamics. Moreover, these inhibitors can provide insights into the broader zinc finger protein family, given the highly conserved nature of zinc finger motifs across different members of the family.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that may broadly decrease protein synthesis, potentially leading to reduced expression of proteins including ZNF792. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Targets the ubiquitin-proteasome pathway, possibly leading to altered transcription factor levels and gene expression, which may affect ZNF792. | ||||||